top of page
LEADERSHIP PAGE
We are one month old! New team members coming soon!
Executive Team
Board of Directors
RICHARD LIPKIN, MBA
Member of the Board
Managing Director @ Easton Capital
Co-founder of The Catalytic Impact Foundation
LENNY MOISE, PHD
Member of the Board
(Pending)
Chief Scientific Officer, SeromYx Systems and Board Member, GAIA Vaccine Foundation
ADVISORS
DOMINIQUE BRIDON, PHD
CEO, Diaccurate
Peptide technology expert with over 35 years of experience
MANON COX, PHD, MBA
CEO, NextWaveBio
Scientific and strategic direction
JUDY LIEBERMAN, MD, PHD
Professor & Chair Immunology, Harvard Medical School
Accomplished immunology expert
ELEANOR RAMOS, MD
CMO/COO, Provention Bio
Clinical development and medical affairs specialist
AMY ROSENBERG, MD
Senior Director, EpiVax
Former Division Director, CDER, FDA
Regulatory Veteran
NICOLE RUGGIERO
Former CEO, EpiVax Therapeutics
Operation and strategy expert
PARTNERS
GREENLIGHT BIOSCIENCES
NOVACELLUM
NYU LANGONE HEALTH
UNIVERSITY OF CHICAGO
MOUNT SINAI
BROWN UNIVERSITY
IMMUNOMIC THERAPEUTICS
SYNTHETIC GENOMICS
21ST CENTURY BIOCHEMICALS
POLYPEPTIDE
INVESTORS
bottom of page